May 2, 2024 CANADA — EssilorLuxottica’s Stellest spectacle lenses for myopia management will be available in sun tints in Canada starting on...
March 1, 2024 By Nabin Paudel, BOptom, PhD Myopia is a growing public health concern that will affect an estimated 4.7 billion...
April 15, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE This randomized clinical trial aimed to evaluate whether Essilor Stellest spectacle...
February 23, 2022 MONTREAL — In late 2021, Essilor announced that it would begin rolling out its myopia management offerings, including Stellest...
sponsored content November 1, 2021 By Mark Bullimore, MCOptom, PhD, FAAO Effective spectacle options for myopia control have finally arrived. They are...
September 21, 2021 CHARENTON-LE-PONT, France — Essilor is slated to present the results from its two-year clinical trial on Stellest lenses at the...
May 17, 2021 CHARENTON-LE-PONT, France — The U.S. Food and Drug Administration (FDA) granted Essilor’s Stellest lenses the Breakthrough Device designation. With...
April 9, 2021 CHARENTON-LE-PONT, France – After two years of a planned three-year clinical trial that tested the efficacy of Essilor’s Stellest...